All other patients were deemed platinum refractory (PR).Results:We identified 3,772 SCLC patients receiving NCCN Category 1 preferred regimens: 43% (1,607) had limited stage, and 57% (2,165) had extensive stage at index. Among patients with extensive stage, 71% (1,541) were PR compared...
Naiyer A. Rizvi, MD:I think for limited-stage patients, they’re unlike extensive stage, for whom maintenance was hard to deliver with only a median cycle of 1. I guess for consolidation, they’re unlikely to progress right away, so you’ll actually have time to deliver the drugs. Jami...
Typically, SCLC presents in senior patients (>70 years) with a substantial smoking history. According to historic Veteran’s Administration Lung Study Group staging criteria, SCLC is simply divided into two respective stages: limited stage (LS-SCLC) and extensive stage SCLC (ES-SCLC). Despite ...
Limited (LTD) Stage Small Cell Lung Cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro Drug Sensitivity Testing (DST)doi:10.1016/0169-5002(91)91917-Z...
- 1994 - 173 - www.sciencedirect.comdoi:10.1016/0169-5002(94)94441-5NoneLung Cancer
To evaluate the impact of prophylactic cranial irradiation (PCI) on the prognosis of patients with limited-stage small cell lung cancer (SCLC) in the era of MRI surveillance. Limited-stage SCLC patients with complete remission (CR) or partial remission (
298 Feasibility study of concurrent cisplatin/etoposide (PE) and thoracic radiotherapy (TRT) followed by weekly dose intensive regimen (CODE) with human granulocyte-colony stimulating factor (G-CSF) for limited stage (LS) small cell lung cancer (SCLC): Report of a Japan clinical oncology group ...
Objective To assess the efficacy and feasibility of chemo-radiotherapy concomitant therapy and 3-dimensional conformal radiotherapy (3DCRT) with limited stage small cell lung cancer (LSCLC).Methods Sixty-five patients with LSCLC were randomly divided into two groups:the treatment group(32 patients)and...
LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial doi:10.1016/j.annonc.2024.08.2324Annals of OncologyS. SenanD.R. SpigelB.C. ChoK. ...
1795P Consolidation serplulimab following concurrent hypofractionated chemoradiotherapy for limited-stage SCLC: Preliminary analysis of phase II ASTRUM-LC01 study doi:10.1016/j.annonc.2024.08.1886Annals of OncologyY. WuL. DengJ. WangT. ZhangJ. CaoX. ZhouJ. DuanN. Bi...